<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>12</Volume><Issue>4</Issue></Journal><ArticleTitle>KINETIC CHARACTERIZATION OF hK6 INHIBITION BY PROTEASE INHIBITOR, SOYBEAN</ArticleTitle><FirstPage>165</FirstPage><LastPage>169</LastPage><AuthorList><Author><FirstName></FirstName><LastName>ALI AWSAT MELLATI</LastName></Author><Author><FirstName></FirstName><LastName>E. ELEFTHERIOS. P. DIAMENDIS</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>06</Day></PubDate></History><Abstract>The kinetic characteristics, of interaction between hK6 (human Kallikrein) and soybean (BBI) , protease
inhibitor and antitumor agent , in the presence of substrate (Phenylalanine –Serine-Arginine)-(7-amino-4-
methyl-coumarin) (FSR-AMC) were investigated. The hK6 were found to bind soybean in two reversible
steps, by slow binding inhibition mechanism. The Ki of the first step binding was 13 nM and Ki* of the
second binding step was 1.6 nM. The microcopic rate constants were calculated as follows: 311 M-1.S-1
for k3
, 0.04×10-6 M-1.S-1 for k –3 , 0.2×10-6 S-1 for k 4 and 0.025×10-6 S-1 for k-4 respectively.The results suggested
that the interaction mechanism between hK6 and soybean was like that of trypsin with this inhibitor but with
rather lower inhibitory constants values.</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/222</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/222/222</pdf_url></Article></Articles>
